PharmiWeb6h
Driving Innovation Through Diversity, Equity, and Inclusion: Insights From Black Book Research's 2025 Study on Healthcare IT
Black Book Research Shares Key Insights and Recognizes Top 21 Vendors Advancing Diversity, Equity, and Inclusion TAMPA, ...
PharmiWeb1h
Netsmart Maintains Leadership in EHR/PM Satisfaction Among Behavioral Health Providers in 2025 Black Book Survey
TAMPA, FLORIDA / ACCESS Newswire / January 22, 2025 / Netsmart has once again been recognized as the top-rated provider of Electronic Health Record (EHR) and Practice Management (PM) solutions for ...
PharmiWeb12h
New study paves way for immunotherapies tailored for childhood cancers
Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s ...
PharmiWeb7h
Phacilitate Awards Katherine High with the 2025 Lifetime Achievement Award at the Advanced Therapies Awards Ceremony in Dallas
Phacilitate, a leading brand that connects advanced therapies industry leaders through inspiring conferences, vibrant communities and market intelligence, today presented Katherine A. High, M.D. with ...
PharmiWeb5h
CMS Doubles Down on Medicare Drug Price Controls, Threatening Patient Access and Innovation
The Centers for Medicare & Medicaid Services (CMS) has announced an additional 15 drugs that will be subject to price controls under the Inflation Reduction Act (IRA). This expansion continues a ...
PharmiWeb5h
VALID Therapeutics Partners With Araceli Biosciences to Advance AI-Driven Drug Discovery
Valid Therapeutics and Araceli Biosciences Partner to Advance AI-Driven Drug Discovery NATICK, Mass., January 22, 2025 (Newswire.com) - VALID, a Techbio startup dedicated to reshaping drug discovery ...
PharmiWeb7h
Elevate Clinical Research Solutions Announces Launch of "Train and Build" Service Line and Webinar Series
Empowering Clinical Research Sites Through Tailored Training and Expertise MADISON, WISCONSIN / ACCESS Newswire / January 22, 2025 / Elevate Clinical Research Solutions is proud to announce the launch ...
PharmiWeb7h
Broughton welcomes FDA authorisation of ZYN nicotine products
Broughton Welcomes FDA Authorisation of ZYN Nicotine Pouches  Broughton, a leading contract research organisation specialising in reduced-risk nicotine products, welcomes the US Food and Drug ...
PharmiWeb12h
ASTRAZENECA RECEIVES TWO POSITIVE NICE RECOMMENDATIONS FOR LUNG CANCER PATIENTS ACROSS ENGLAND AND WALES
AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...
PharmiWeb10h
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million
CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...
PharmiWeb10h
Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment ...
PharmiWeb8h
OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...